標(biāo)題: Titlebook: Gender and Migraine; Antoinette Maassen van den Brink,E. Anne MacGregor Book 2019 Springer Nature Switzerland AG 2019 migraine in women.fe [打印本頁(yè)] 作者: ACID 時(shí)間: 2025-3-21 16:41
書目名稱Gender and Migraine影響因子(影響力)
書目名稱Gender and Migraine影響因子(影響力)學(xué)科排名
書目名稱Gender and Migraine網(wǎng)絡(luò)公開(kāi)度
書目名稱Gender and Migraine網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Gender and Migraine被引頻次
書目名稱Gender and Migraine被引頻次學(xué)科排名
書目名稱Gender and Migraine年度引用
書目名稱Gender and Migraine年度引用學(xué)科排名
書目名稱Gender and Migraine讀者反饋
書目名稱Gender and Migraine讀者反饋學(xué)科排名
作者: Adornment 時(shí)間: 2025-3-21 21:52 作者: 前奏曲 時(shí)間: 2025-3-22 04:22 作者: paroxysm 時(shí)間: 2025-3-22 05:10 作者: consolidate 時(shí)間: 2025-3-22 09:23 作者: Accord 時(shí)間: 2025-3-22 13:51 作者: Accord 時(shí)間: 2025-3-22 18:52 作者: 我要沮喪 時(shí)間: 2025-3-22 23:26 作者: CHAFE 時(shí)間: 2025-3-23 01:51
Buchführung und Jahresabschlussrawal hypothesis,” migraine episodes are precipitated by a decline in estrogen, as may occur in the menstrual period [1]. Therefore, exogenous estrogens such as those contained in combined hormonal contraceptives (CHC) might interfere with the course of headache in women with migraine. In most cases作者: CANT 時(shí)間: 2025-3-23 07:11
Gottfried B?hr,Wolf F. Fischer-Winkelmann, POC does not increase frequency of migraine attacks and does not initiate migraine. The continuous use of this contraceptive might contribute to the good tolerability in migraineurs. Only for the progestin-only pill with desogestrel 75?μg has it been demonstrated in several studies that it exerts 作者: engender 時(shí)間: 2025-3-23 10:44 作者: 反感 時(shí)間: 2025-3-23 15:45 作者: Range-Of-Motion 時(shí)間: 2025-3-23 19:19 作者: 分解 時(shí)間: 2025-3-23 23:36
Book 2019nical relevance of such mechanisms and to the best clinical treatment for migraine patients..As the first book entirely devoted to this topic, it will be of interest to researchers and practitioners in the fields of neurology, internalmedicine, endocrinology, physiology and pharmacology..作者: 使長(zhǎng)胖 時(shí)間: 2025-3-24 04:42 作者: 地殼 時(shí)間: 2025-3-24 09:40
Headache and Pregnancy,al hypertension (IIH), and pituitary apoplexy. The preferable management of primary headache during pregnancy and breastfeeding should be non-pharmacological, and only if it is inadequate, the use of medications should be driven by a choice that takes into account all the benefits and possible risks作者: Dendritic-Cells 時(shí)間: 2025-3-24 11:52
2197-652X s..As the first book entirely devoted to this topic, it will be of interest to researchers and practitioners in the fields of neurology, internalmedicine, endocrinology, physiology and pharmacology..978-3-030-02988-3Series ISSN 2197-652X Series E-ISSN 2197-6538 作者: Multiple 時(shí)間: 2025-3-24 16:41 作者: 戲法 時(shí)間: 2025-3-24 20:32 作者: Fissure 時(shí)間: 2025-3-25 00:21 作者: 無(wú)意 時(shí)間: 2025-3-25 04:25 作者: Evocative 時(shí)間: 2025-3-25 08:32 作者: 整頓 時(shí)間: 2025-3-25 14:55
Migraine and Use of Progestin-Only Contraception,, POC does not increase frequency of migraine attacks and does not initiate migraine. The continuous use of this contraceptive might contribute to the good tolerability in migraineurs. Only for the progestin-only pill with desogestrel 75?μg has it been demonstrated in several studies that it exerts 作者: STEER 時(shí)間: 2025-3-25 16:45 作者: DEBT 時(shí)間: 2025-3-25 21:33
Gender Differences in Imaging Studies in Migraine,e and >14 headache days in chronic migraine) that last 4–72?h. Migraine is considered by the World Health Organization (WHO) to be in the top 20 causes of disability worldwide [1] and affects patients during their formative and most productive periods of their lives. In the United States, migraine a作者: ATRIA 時(shí)間: 2025-3-26 01:05
Transgender and Migraine,s of oestrogen. Hence, migraine is likely to be affected by hormones used for transgender treatment. Of the very limited data available, the prevalence of migraine increases in transgender women using oestrogen and reduces in transgender men using testosterone. The increased prevalence of migraine a作者: incite 時(shí)間: 2025-3-26 06:07 作者: 離開(kāi)就切除 時(shí)間: 2025-3-26 08:57
,System der doppelten Buchführung,onal changes are more resistant to pharmacological treatment. This chapter describes the current knowledge on the role of hormonal fluctuations throughout the menstrual cycle in migraine patients. Further, specific treatments for pure menstrual migraine, menstrually related migraine, and perimenopausal migraine are discussed.作者: 我說(shuō)不重要 時(shí)間: 2025-3-26 16:30 作者: enfeeble 時(shí)間: 2025-3-26 19:09
Book 2019graine is roughly three times more common in women than in men, and also highly depends on hormonal milestones – such as menarche, menstruation, pregnancy and menopause – particular attention is devoted to the role of female sex hormones in this disease.?. The first chapters present general data on 作者: 昏暗 時(shí)間: 2025-3-26 22:14 作者: 細(xì)節(jié) 時(shí)間: 2025-3-27 04:42 作者: 誹謗 時(shí)間: 2025-3-27 09:11 作者: indemnify 時(shí)間: 2025-3-27 13:20
Cardiovascular Risk of Migraine in Men and Women,n men. The assumption that the presence or absence of cardiovascular disease influences the additional cardiovascular risk associated with migraine therefore may have consequences for the choices of pharmacological antimigraine treatment.作者: 藥物 時(shí)間: 2025-3-27 16:38
Verbuchung weiterer Produktionsfaktorenved with disability among women and men under 50?years of age and is estimated to cost the European society more than 27 billion euros annually. Women report longer duration of attacks and a greater migraine-related disability, while men are more likely to experience longer periods of remission.作者: 錯(cuò) 時(shí)間: 2025-3-27 20:26
Buchführung und Jahresabschlussraine prophylaxis (e.g., menstrual migraine [MM]). A complex and still unknown interaction between the vascular actions of estrogens and the vascular alterations of subjects with migraine may also explain the highly increased risk of cardiovascular events among women with migraine using CHC [2].作者: Mirage 時(shí)間: 2025-3-27 21:58
Gottfried B?hr,Wolf F. Fischer-Winkelmannther studies could lead to the development of sex-specific treatments..This chapter provides a summary of the studies that have evaluated the sex differences in CGRP, in both preclinical and clinical models of migraine and their possible implications for migraine pathophysiology and treatment.作者: 無(wú)辜 時(shí)間: 2025-3-28 04:06 作者: amphibian 時(shí)間: 2025-3-28 10:09
Epidemiology of Migraine in Men and Women,ved with disability among women and men under 50?years of age and is estimated to cost the European society more than 27 billion euros annually. Women report longer duration of attacks and a greater migraine-related disability, while men are more likely to experience longer periods of remission.作者: 我不明白 時(shí)間: 2025-3-28 14:07 作者: 柔聲地說(shuō) 時(shí)間: 2025-3-28 15:30 作者: 鴕鳥 時(shí)間: 2025-3-28 21:45 作者: RECUR 時(shí)間: 2025-3-29 00:05 作者: phytochemicals 時(shí)間: 2025-3-29 03:35
